{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:17:01Z","timestamp":1789064221469,"version":"build-2803163510"},"reference-count":5,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ugeskr L\u00e6ger"],"abstract":"<jats:p>Acute pancreatitis (AP) is a sudden inflammation of the pancreas which often manifests as a mild disease but can be associated with high morbidity and mortality. Drug-induced AP is rare and most likely underdiagnosed. Vedolizumab is a human monoclonal antibody with gut-selective integrin antagonist effect, and it is used for treatment of inflammatory bowel disease (IBD). Budesonid is a glucocorticoid which is released in the colon and it is also used in IBD treatment. This is a case report where vedolizumab or budesonide caused acute pancreatitis in a young man with ulcerative colitis.<\/jats:p>","DOI":"10.61409\/v01240025","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T08:35:03Z","timestamp":1718008503000},"page":"1-3","source":"Crossref","is-referenced-by-count":1,"title":["Acute pancreatitis in an ulcerative colitis patient treated with vedolizumab and budesonide"],"prefix":"10.61409","author":[{"given":"Christel Dupont","family":"Ravn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Bendix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Lyhne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"40208","published-online":{"date-parts":[[2024,5,27]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Lankisch PG, Apte M, Banks PA. Acute pancreatitis. Lancet. 2015;386(9998):85-96. https:\/\/doi.org\/10.1016\/S0140-6736(14)60649-8","DOI":"10.1016\/S0140-6736(14)60649-8"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Forsmark CE, Vege SS, Wilcox CM et al. Acute pancreatitis. N Engl J Med 2016;375(20):1972-1981. https:\/\/doi.org\/10.1056\/NEJMra1505202","DOI":"10.1056\/NEJMra1505202"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Massironi S, Fanetti I, Vigan\u00f2 L et al. Systematic review - pancreatic involvement in inflammatory bowel disease. Aliment Pharmacol Ther. 2022;55(12):1478-1491. https:\/\/doi.org\/10.1111\/apt.16949","DOI":"10.1111\/apt.16949"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Lin E, Katz S. Acute pancreatitis in a patient with ulcerative colitis on vedolizumab. Inflamm Bowel Dis. 2020;26;5(5):e44. https:\/\/doi.org\/10.1093\/ibd\/izaa042","DOI":"10.1093\/ibd\/izaa042"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Picardo S, So K, Venugopal K et al. Vedolizumab-induced acute pancreatitis: the first reported clinical case. BMJ Case Rep. 2018;2018:bcr2017222554. https:\/\/doi.org\/10.1136\/bcr-2017-222554","DOI":"10.1136\/bcr-2017-222554"}],"container-title":["Ugeskrift for L\u00e6ger"],"original-title":[],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T11:41:07Z","timestamp":1718970067000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/videnskab\/V01240025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,27]]},"references-count":5,"URL":"https:\/\/doi.org\/10.61409\/v01240025","relation":{},"ISSN":["0041-5782","1603-6824"],"issn-type":[{"value":"0041-5782","type":"print"},{"value":"1603-6824","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,27]]}}}